NM

Nicholas Mitsiades

DI Dana-Farber Cancer Institute: 4 patents #223 of 1,343Top 20%
BM Baylor College Of Medicine: 2 patents #185 of 907Top 25%
PS Pharma Mar, S.A.: 1 patents #71 of 189Top 40%
📍 Boston, MA: #1,241 of 5,993 inventorsTop 25%
🗺 Massachusetts: #20,307 of 88,656 inventorsTop 25%
Overall (All Time): #834,502 of 4,157,543Top 25%
6
Patents All Time

Issued Patents All Time

Showing 1–6 of 6 patents

Patent #TitleCo-InventorsDate
10227656 Diagnostic/prognostic marker and therapeutic target for cancer Bin He, Rainer B. Lanz, Qin Feng 2019-03-12
10082510 SRC-2 use as metabolic biomarker for diagnosis and treatment of metastatic prostate cancer Bert W. O'Malley, Subhamoy Dasgupta, Arun Sreekumar, Sean E. Mcguire 2018-09-25
8685954 Methods and compositions for treating cancer using proteasome inhibitors Kenneth C. Anderson, Teru Hideshima, Constantine S. Mitsiades 2014-04-01
8466147 Use of reversine and analogs for treatment of cancer Kenneth C. Anderson, Joseph Negri, Douglas W. McMillin, Constantine S. Mitsiades 2013-06-18
8026230 Methods and compositions for treating cancer using proteasome inhibitors Kenneth C. Anderson, Teru Hideshima, Constantine S. Mitsiades 2011-09-27
7381703 Aplidine for multiple myeloma treatment Joseph R. Bertino, Daniel Medina, Glynn Thomas Faircloth, Constantine S. Mitsiades, Kenneth C. Anderson 2008-06-03